Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials

BACKGROUND: Tuberculosis (TB) remains a leading cause of death worldwide, with 98% of cases occurring in low- and middle-income countries (LMICs). The only vaccine licenced for the prevention of TB has limited protection for adolescents, adults and vulnerable populations. A safe and effective vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Lydia, Gracie, Lara, Kidy, Farah, Thomas, G. Neil, Nirantharakumar, Krishnarajah, Greenfield, Sheila, Manaseki-Holland, Semira, Ward, Derek J., Gooden, Tiffany E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951834/
https://www.ncbi.nlm.nih.gov/pubmed/36829123
http://dx.doi.org/10.1186/s12879-023-08092-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951834/
https://www.ncbi.nlm.nih.gov/pubmed/36829123
http://dx.doi.org/10.1186/s12879-023-08092-4

Ejemplares similares